DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

42.81 -0.42 (-0.97%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $42.81 -0.97%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.17
Previous Close $43.23
Daily Range $42.53 - $43.58
52-Week Range $30.05 - $44.95
Market Cap $5.3B
P/E Ratio -65.50
Dividend (Yield) $0.00 (0.0%)
Volume 1,145,763
Average Daily Volume 1,201,467
Current FY EPS -$0.76




Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

4 Big Biotech Companies to Sell Now

Otonomy, Renren And Other Names To Watch Heading Into Next Week

Insiders keep on buying Macerich Co and Seattle Genetics

Trade-Ideas: Seattle Genetics (SGEN) Is Today's Post-Market Leader Stock

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) Is Today's Perilous Reversal Stock

Insider Trading Alert - SGEN, NSP And TSCO Traded By Insiders

See More SGEN News...

SGEN's Top Competitors

SGEN $42.81 (-0.97%)
Current stock: SGEN
AMGN $159.01 (-2.79%)
Current stock: AMGN
GILD $109.77 (-1.74%)
Current stock: GILD
BIIB $392.88 (-1.45%)
Current stock: BIIB